© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Name: Thrombin, derived from human plasma, plays a critical role in the lab for research and medical applications, used often in coagulation studies.
Appearance: Off-white or slightly yellow powder or lyophilized cake, usually reconstituted in sterile water.
Common Uses: Stops bleeding during surgeries, supports clotting studies, assists in cell biology protocols.
Origin: Processed from pooled human plasma following purification and viral reduction steps to minimize contamination risks.
Health Risks: Thrombin sourced from human plasma carries risks tied to bloodborne pathogens, like hepatitis B, C, or HIV, even with stringent screening methods in place.
Inhalation Risks: Proper reconstitution and handling prevent powder inhalation; dust can trigger mild respiratory irritation.
Skin and Eye Contact: Exposure can cause irritation; absorption through skin is rare, yet broken skin increases risk, making gloves crucial.
Allergic Reactions: Some workers report hypersensitivity or allergic responses, likely due to trace plasma proteins.
Flammability: Not classified as flammable in powder or solution form under standard conditions.
Active Ingredient: Highly purified human thrombin, with specific activity commonly over 1000 IU/mg.
Stabilizers & Excipients: Commonly contains sodium chloride, calcium chloride, and sometimes albumin from human plasma.
Protein Content: Dominated by the active enzyme, trace residual proteins may be present after purification.
Contaminant Monitoring: Manufacturers apply viral inactivation and removal measures, but absolute sterility cannot be guaranteed.
Inhalation: Go outside for fresh air. Persistent symptoms like coughing or dizziness call for seeking medical attention.
Skin Contact: Rinse area thoroughly with water. For visible irritation, wash with soap and water and consider reporting to occupational health.
Eye Contact: Flush the eye with water for at least 15 minutes. If redness or discomfort does not resolve, medical assessment makes sense.
Ingestion: Laboratory workers should not eat or drink where thrombin is handled; if accidental ingestion happens, seek prompt medical review.
Splashes or Accidents: Remove contaminated clothing and follow up with immediate washing to minimize risks.
Suitable Extinguishing Media: Water spray, foam, dry chemical, or carbon dioxide can control fires involving packaging materials.
Unusual Hazards: Product itself does not support combustion, but packaging may burn and emit toxic gases.
Protective Equipment: Firefighters require self-contained breathing apparatus and full protective gear, especially during major incidents.
Special Precautions: Avoid inhaling fumes from burning packaging, as combustion by-products often irritate the respiratory tract.
Personal Protection: Wear gloves, lab coats, and safety eyewear. Respiratory protection matters for spill cleanup of dry powder.
Containment: Limit the spill to a small area and avoid generating dust. Absorb with dampened materials or disposable towels.
Cleanup: Clean thoroughly with appropriate disinfectants known to inactivate biological agents. Dispose of cleanup waste by established biohazard protocols.
Decontamination: Wash hands and any exposed skin immediately after handling.
Reporting: Always report significant spills to your safety officer for assessment and follow-up.
Handling Precautions: Only trained staff in well-ventilated biosafety cabinets should handle reconstitution and transfer. Use small batches to minimize exposure.
Hygiene: No eating or drinking near workstations; regular handwashing reduces unintended exposure. Avoid touching face or nose before washing up.
Storage Conditions: Store below -20°C before use in tightly sealed containers to protect from moisture and contamination.
In-use Practice: Reconstituted samples should be kept cold and used promptly, as enzyme activity falls after prolonged exposure to room temperature.
Incompatibilities: Keep containers away from strong oxidizers or acids; moisture degrades powder rapidly.
Ventilation: Biosafety cabinet use protects both the worker and the product.
Personal Protective Equipment: Gloves (nitrile or latex), lab coats, safety goggles offer basic protection; face shields for splash hazards.
Engineering Controls: Biohazard disposal bins, easy access to eyewash stations, and handwashing sinks matter in labs working with plasma derivatives.
Exposure Limits: Occupational exposure limits for biological products focus on universal precautions, not established airborne limits.
Training: Regular training on bloodborne pathogen protocols forms the backbone of a safe lab culture.
Form: Powdery solid until reconstituted; becomes a clear to slightly hazy solution in sterile water.
Odor: Nearly odorless in typical lab concentrations.
Solubility: Readily soluble in water; forms active enzyme solution on mixing.
pH: Typically near physiological, around 7.0-7.5, for dissolved samples.
Stability: Stable at low temperatures in original packaging; loses activity quickly if exposed to heat or moisture.
Chemical Stability: Stable in dry, cold, airtight containers; moisture and repeated freeze-thaw cycles destroy enzyme activity.
Reactivity: Rapidly degrades in acidic or basic conditions. Oxidizing agents destabilize the protein.
Decomposition: No dangerous decomposition products under normal storage; heat or acid can denature protein, rendering it inactive, but not toxic.
Polymerization: Not known to undergo hazardous polymerization.
Storage Hazards: Long-term exposure to ambient humidity or temperature increases risk of loss of potency.
Acute Effects: Lab technicians using proper PPE rarely report acute toxicity from external exposure; accidental injection or mucosal contact presents more of a risk.
Chronic Effects: No evidence links chronic exposure to severe health consequences, but possible sensitization over time may occur among those with extensive handling.
Exposure Symptoms: Animal studies show minimal toxicity; human studies focus on allergic responses, not lethal outcomes.
Carcinogenicity: No classification as a carcinogen; plasma-derived proteins don’t fall into common cancer-causing categories based on current science.
Other Risks: Undetected infectious agents represent the largest theoretical hazard.
Environmental Fate: Human plasma proteins biodegrade quickly in wastewater treatment plants; no evidence for environmental persistence.
Aquatic Toxicity: No specific studies show negative impact; expected to break down like other biologicals.
Bioaccumulation: Does not accumulate in wild organisms.
Spill Response: Routine spills and rinses unlikely to affect soil or water bodies if lab waste is managed by best practices.
Disposal Minimizes Risk: Proper containment in biohazardous waste streams protects environments around labs and clinics.
Lab Waste Stream: Thrombin residues, vials, and contaminated PPE go into biohazard containers.
Disposal Method: Incineration or approved medical waste autoclaving ensures destruction of potential infectious agents.
Minimization: Small-scale usage and centralized disposal help lower risk; never pour solutions down the drain.
Employee Training: Regular reminders about proper disposal reinforce lab safety culture.
Environmental Stewardship: Compliance with waste regulations maintains good standing with local and national authorities.
Shipping Class: Typically shipped as UN3373 Biological Substance, Category B in leak-proof, insulated packaging on dry ice.
Labeling: Biological substance indicators, clear hazard labeling, and transport documents travel with the shipment.
Temperature Maintenance: Cold-chain integrity preserves enzyme activity during transit.
Worker Training: Staff handling shipments undergo training in biosafety and transport rules.
Incident Response: Spills or damage during transit require clean-up by certified personnel using proper PPE and protocols.
Risk Management: Regulated under bloodborne pathogen standards and biosafety laws in many countries.
Compliance: OSHA, CDC, and similar bodies set requirements for lab use of human-derived reagents.
Transport Regulation: Follows international guidelines for infectious and potentially hazardous biological substances.
Reporting: Major exposures call for immediate supervisor and health authority notification.
Ongoing Assessment: Periodic review of protocols ensures compliance and safety adaptations as new information emerges.
